Alterity Therapeutics

ATHENasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$80.660 M

$4.45 -2.41%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#317RallybioRLYB$85.6M
#318LifevantageLFVN$85.3M
#319Alterity TherapeuticsATHE$80.7M
#320Telomir PharmaceuticalsTELO$79.8M
#321Gain TherapeuticsGANX$77.6M

Where these numbers come from

Share counts and financials for Alterity Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.